Abstract
Recognition that resources are limited has led to a growing concern for efficiency in the provision of health care in the UK, which has been heightened with the advent of the recent NHS reforms. Purchasing agencies, such as fundholding general practitioners, and providers, such as hospital trusts, are now expected to take on the more traditional economic roles of consumers and producers, responding to market mechanisms and improving, in the process, the efficiency of health care delivery [48]. Clinton’s health reform plan for the US takes a parallel position, whereby it is proposed that large groups of American employers act as purchasing agencies who will negotiate with insurers. They, in turn, will negotiate with doctors to find high quality care at the lowest cost [42]. It should not be surprising, therefore, to learn that the demand for economic skills has grown alongside these changes. One of the most important sets of skills that economists can offer in this context is that of economic appraisal techniques. These help decision makers (both purchasers and providers) to address three particular questions: which health care programmes are worthwhile undertaking, whether alternative configurations of the programmes, other than the existing ones, result in better value for money and how such programmes should be organised so that scarce resources are not needlessly wasted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bethwaite J, Rayner T, Bethwaite P (1986) Economic aspects of screening for cervical cancer in New Zealand. NZ Med J 99:747–751.
Bourne TH, Campbell S, Reynolds KM et al. (1993) Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br Med J 306:1025–1029.
Brown J, Sculpher M (1993) Economics of screening programmes to prevent cervical cancer. Contemp Rev Obstet Gynaecol 5:221–229.
Buxton M, Ashby J, O’Hanlon M (1987) Alternative methods of valuing health states. HERG Discussion Paper No. 2. Health Economics Research Group, Brunei University.
Cairns J (1992) Discounting and health benefits: another perspective. Health Econ 1:76–79.
Cairns J, Shackley P (1993) Sometimes sensitive, seldom specific: a review of the economics of screening. Health Econ 2:43–53.
Campion MJ, Brown JR, McCance DJ et al. (1988) Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 95:175–181.
Chadwick DJ, Kemple T, Astley JP et al. (1991) Pilot study of screening for prostate cancer in general practice. Lancet 338:613–616.
Chamberlain J (1990) Is screening for colorectal cancer worthwhile? Br J Cancer 62:1–3.
Chodak GW, Schoenberg HW (1984) Early detection of prostate cancer by routine screening. JAMA 252:3261–3264.
Coppleson LW, Brown B (1976) The prevention of carcinoma of the cervix. Am J Obstet Gynecol 125:153–159.
Cristofolini M, Bianchi R, Boi S et al. (1993) Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer 71:370–374.
de Haes JCJM, de Koning HJ, van Oortmarssen GJ, van Agt HME, de Bruyn AE, van der Maas PJ (1991) The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 49:538–544.
de Koning HJ, van Ineveld BM, van Oortmarssen GJ et al. (1991) Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49:531–537.
Drummond MF (1989) Principles of economical appraisal in health care. Oxford University Press, Oxford.
Drummond MF, Stoddard GL, Torrance GW (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford
Drummond MF, Torrance G, Mason J (1993) Cost-effectiveness league tables: More harm than good? Soc Sci Med 37:33–40.
Eddy DM (1990) Screening for cervical cancer. Ann Internal Med 113:214–226.
Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P (1989) Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 60:781–784.
Feaver GP (1990) Screening for oral cancer and precancer. Dent Pract May, 16–18.
Forrest P (1988) Breast Cancer Screening. Report to the Health Minister of England, Wales, Scotland and Northern Ireland. Department of Health and Social Security, HMSO, London.
Fraser MN, Clarke PR (1992) Cost-effectiveness of breast cancer screening. The Breast 1:169–172.
Gerard K, Mooney G (1993) QALY league tables: handle with care. Health Econ 2:59–64.
Gram IT, Lund E, Slenker SE (1990) Quality of life following a false positive mammogram. Br J Cancer 62:1018–1022.
Gram IT, Slenker SE (1992) Cancer anxiety and attitudes towards mammography among screening attenders, nonattenders and women never invited. Am J Public Health 82:249–251.
Grimes DS (1988) Value of a negative cervical smear. Br Med J 296:1363.
Hall J (1992) A cost-utility analysis of mammography screening in Australia. Soc Sci Med 34:993–1004.
Hardcastle JD, Chamberlain J, Sheffield J et al. (1989) Randomised controlled trial of faecal occult blood screening for colorectal cancer. Results of the first 107 349 subjects. Lancet i:1160–1164.
Jacobs I, Prys Davies A, Bridges J et al. (1993) Prevalence screening for ovarian cancer in post menopausal women by CA 125 measurement and ultrasonography. Br Med J 306:1030–1034.
Knox EG (1976) Ages and frequencies for cervical cancer screening. Br J Cancer 34:444–452.
Koopmanschap MA, Lubbe KTN, van Oortmarssen GJ, van Agt HMA, van Ballegooijen M, Habbema JDF (1990) Economic aspects of cervical cancer screening. Soc Sci Med 30:1081–1987.
Loomes G, McKenzie L (1989) The use of QALYs in health care decision making. Soc Sci Med 28:299–308.
Love RR, Fryback DG, Kimbrough SR (1985) A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination. Med Decis Making 5(3):263–178.
MacLean U, Sinfield D, Klein S, Harden B (1984) Women who decline breast screening. J Epidemiol Community Health 38:278–283.
Marteau TM, Walker P, Giles J, Smail M (1990) Anxieties in women undergoing colpos-copy. Br J Obstet Gynaecol 97:859–861.
Mason J, Drummond M, Torrance G (1993) Some guidelines of the use of cost effectiveness league tables. Br Med J 306:570–572.
Mooney G, Olsen JA (1991) QALYs: Where next? In: McGuire A, Fenn P, Mayhew K (eds) Providing health care. Oxford University Press, Oxford, pp 120–140.
Nally F (1988) Oral cancer (letter). Br Dent J 165:240.
Nord E (1992) Methods for quality adjustment of life years. Soc Sci Med 34(5):559–569.
Parsonage M, Neuburger H (1992) Discounting health benefits. Health Econ 1:71–76.
Pedersen KV, Carlsson P, Varenhorst E, Lofman O, Berglund K (1990) Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. Br Med J 300:1041–1044.
Roberts JC (1993) How Clinton’s reforms compare with the NHS. Br Med J 307:820.
Robinson R (1993) Cost and cost-minimisation analysis. Br Med J 307:726–728.
Rosser R, Kind P (1978) A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol 7:347–358.
Sackett DL, Torrence GW (1978) The utility of different health states as perceived by the general public. J Chron Dis 31:697–704.
Schneider J, Twiggs LB (1972) The cost of carcinoma of the cervix. Obstet Gynecol 40:851–858.
Schroder FH (1993) Prostate cancer: to screen or not to screen? Br Med J 306:407–408.
Secretaries of State for Health, Wales, Northern Ireland and Scotland (1989) Working for patients: the health service: caring for the 1990s. HMSO, London.
Simpson P, Chamberlain J, Gravelle HSE (1978) Choice of screening tests. J Epidemiol Community Health 32:166–170.
Smith A, Chamberlain J (1987) Managing cervical screening. In: Information technology in health care, Issue 4. Kluwer Publishing Ltd, Kingston upon Thames, pp 2–12.
Torrance GW (1986) Measurement of health-state utilities for economic appraisal: A review. J Health Econ 5:1–30.
van Ballegooijen M, Habbema JDF, van Oortmarssen GJ, Koopmanschap MA, Lubbe JTN, van Agt HME (1992) Preventive pap-smears: balancing costs, risks and benefits. Br J Cancer 65:930–933.
van Ballegooijen M, Koopmanschap MA, Tjokrowardojo AJS, van Oortmarssen GJ (1992) Care and costs for advanced cervical cancer. Eur J Cancer 28A:1703–1708.
Walker A, Whynes DK, Thomas WM, Chamberlain JO, Hardcastle JD (1991) Retesting positive results in screening for colorectal cancer: a marginal analysis. Appl Econ 23:1015–1017.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brown, J. (1996). Economic Aspects of Cancer Screening. In: Chamberlain, J., Moss, S. (eds) Evaluation of Cancer Screening. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-3044-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3044-4_10
Publisher Name: Springer, London
Print ISBN: 978-3-540-19957-1
Online ISBN: 978-1-4471-3044-4
eBook Packages: Springer Book Archive